Ginkgo biloba is a pure herbal antioxidant that improves circulation and helps maintain nerve health. Research shows Ginkgo biloba can help improve memory, brain function and attention span. It also relieves depression, anxiety, headaches, ringing in the ears (tinnitus), dizziness and cramps caused by poor circulation. Ginkgo biloba extract is useful for slowing aging related macular degeneration of the eye and controlling cataracts. It treats diabetic complications, such as nerve damage, and improves oxygen supply and overall nerve health. SOLALís Ginkgo Biloba Extract is 10-50 times more potent than other forms of Ginkgo biloba.
Not safe for use during pregnancy. Safety in breastfeeding has not been established. Warfarin and other anticoagulants: Ginkgo biloba has been shown to reduce platelet aggregation and blood clotting. The use with anticoagulants should be avoided or carefully monitored. Medicines that have anticoagulant effects include Aspirin, Clopidogrel, Dalteparin, Enoxaparin, Heparin, Indomethacin, Ticlopidine, Warfarin, and others.
Ibuprofen: Concurrent use could lead to an increased risk of spontaneous bleeding.
Alprazolam: Ginkgo biloba may decrease the effectiveness of Alprazolam.
Anticonvulsants: Ginkgo biloba may reduce the effectiveness of anticonvulsants and increase the risk of seizures. Some anti-epileptic medicines include Phenobarbital, Primidone, Valproic Acid, Gabapentin, Carbamazepine, Phenytoin and others.
Antidiabetic medicines: Ginkgo biloba seems to alter insulin secretion and metabolism, and might affect glucose levels in type 2 diabetics. Some antidiabetic medicines include Glimepiride, Glyburide, Insulin, Pioglitazone, Rosiglitazone and others.
Seizure threshold lowering medicines: Concurrent use with seizure threshold lowering medicines could increase the changes of seizures. Some medicines that lower seizure threshold include: anesthetics, antiarrhythmics, antibiotics (Amphotericin, Penicillin, Cephalosporins, Imipenem), antidepressants (Bupropion, others), antihistamines (Cyproheptadine, others), immunosuppressants (Cyclosporine), narcotics (Fentanyl, others), stimulants (Methylphenidate), Theophylline.
Trazodone: Concurrent use with Ginkgo biloba has been associated with coma.
Efavirenz: Concurrent use may lead to decreased efavirenz concentrations and increased viral load.
Fluoxetine, Buspirone, Melatonin and St Johns Wort: Ginkgo biloba used in combination with these medicines might cause hypomania in individuals with depression.
Adults over 18 years of age: Take 1 capsule daily or as recommended by your health care provider.
60 x Solal Ginkgo Biloba Extract Capsules
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
- Indications: Herbal medicinal product for the improvement of (age-associated) cognitive impairment and of quality of life in mild dementia.
- Adults: Take 1 capsule daily.
- Individuals who experience no symptomatic improvement after 3 months, or if pathological symptoms should intensify, the healthcare practitioner should check whether continuation of treatment is still justified. Individuals with pathological increased bleeding tendency (haemorrhagic diathesis) should consult a healthcare practitioner prior to use. Individuals taking medication for diabetes, high blood pressure, or seizures should contact their healthcare practitioner prior to use. Discontinue this product 3 to 4 days prior to elective surgery. Ginkgo biloba may promote the onset of seizures in individuals suffering from epilepsy and should be used with caution.
- Each capsule contains the following active ingredient: 250mg Ginkgo biloba extract (24% flavone glycosides and 6 % terpene lactones)
- Inactive ingredients: Hypromellose (cellulose) vegetarian capsule shell, microcrystalline cellulose, magnesium stearate (vegetarian – flow agent), silicon dioxide.
- Suitable for vegans and vegetarians.
Review This Product
No reviews yet - be the first to create one!